Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40,762,262
-
Total 13F shares
-
34,672,382
-
Share change
-
+1,171,979
-
Total reported value
-
$321,430,455
-
Put/Call ratio
-
100%
-
Price per share
-
$9.27
-
Number of holders
-
117
-
Value change
-
+$7,599,744
-
Number of buys
-
52
-
Number of sells
-
63
Institutional Holders of Pulmonx Corp - COM (LUNG) as of Q1 2024
As of 31 Mar 2024,
Pulmonx Corp - COM (LUNG) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,672,382 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, FMR LLC, BlackRock Inc., Point72 Asset Management, L.P., MORGAN STANLEY, VANGUARD GROUP INC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.